Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[ureterocele prolapse through the urethra: a case report].
Yokonishi T, Ito Y, Matsumoto T, Osaka K, Umemoto S, Komiya A, Kobayashi K, Sakai N, Noguchi S, Kishi H. Yokonishi T, et al. Among authors: osaka k. Hinyokika Kiyo. 2010 Jul;56(7):385-7. Hinyokika Kiyo. 2010. PMID: 20724813 Free article. Japanese.
Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
Ohtake S, Kawahara T, Kasahara R, Ito H, Osaka K, Hattori Y, Teranishi JI, Makiyama K, Mizuno N, Umemoto S, Miyoshi Y, Nakaigawa N, Miyamoto H, Yao M, Uemura H. Ohtake S, et al. Among authors: osaka k. Biomed Res Int. 2016;2016:9846823. doi: 10.1155/2016/9846823. Epub 2016 Sep 8. Biomed Res Int. 2016. PMID: 27822480 Free PMC article.
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Nakaigawa N, Kondo K, Kaneta T, Tateishi U, Minamimoto R, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Hayashi N, Osaka K, Muraoka K, Izumi K, Kawahara T, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Inoue T, Yao M. Nakaigawa N, et al. Among authors: osaka k. Cancer Chemother Pharmacol. 2018 Apr;81(4):739-744. doi: 10.1007/s00280-018-3542-7. Epub 2018 Feb 20. Cancer Chemother Pharmacol. 2018. PMID: 29464355
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.
Noguchi G, Nakaigawa N, Umemoto S, Kobayashi K, Shibata Y, Tsutsumi S, Yasui M, Ohtake S, Suzuki T, Osaka K, Muraoka K, Hasumi H, Kondo K, Igarashi Y, Sasada T, Kishida T, Yao M. Noguchi G, et al. Among authors: osaka k. Cancer Chemother Pharmacol. 2020 Jul;86(1):75-85. doi: 10.1007/s00280-020-04088-y. Epub 2020 Jun 14. Cancer Chemother Pharmacol. 2020. PMID: 32537714
[A CASE OF EXTRASKELETAL EWING'S SARCOMA IN THE RETROPERITONEUM].
Kobayashi K, Tsutsumi S, Noguchi G, Osaka K, Umemoto S, Takeyama M, Hiruma T, Kishida T. Kobayashi K, et al. Among authors: osaka k. Nihon Hinyokika Gakkai Zasshi. 2020;111(3):89-93. doi: 10.5980/jpnjurol.111.89. Nihon Hinyokika Gakkai Zasshi. 2020. PMID: 34305094 Free article. Japanese.
318 results